Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Muir

Showing results (21-30 of 187) with videos related to

Pageof 19
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 12, 2017
Hepatocellular Carcinoma SurveillanceJanice H Jou, Andrew J Muir
The New England Journal of Medicine|June 29, 2012
Overcoming barriers to care for hepatitis CPaul J Clark, Andrew J Muir
Journal of Clinical Gastroenterology|June 25, 2002
A survey of current liver biopsy practice patternsAndrew J Muir, James F Trotter
Hepatology (Baltimore, Md.)|November 30, 2006
Growth factors during HCV therapy may be "cost-effective", but are they "effective"?Andrew J Muir, John G McHutchison
Gastroenterology Clinics of North America|September 7, 2011
Emerging therapies in hepatitis C: dawn of the era of the direct-acting antiviralsAlison B Jazwinski, Andrew J Muir
Therapeutic Advances in Chronic Disease|November 17, 2015
Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomesJulius M Wilder, Andrew J Muir
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 22, 2019
Great Expectations: Can Magnetic Resonance Elastography Accelerate Progress in Primary Sclerosing Cholangitis Research?Mustafa R Bashir, Andrew J Muir
Gastroenterology & Hepatology|April 30, 2011
Direct-acting antiviral medications for chronic hepatitis C virus infectionAlison B Jazwinski, Andrew J Muir
JAMA|July 20, 2016
Evaluation of New-Onset AscitesYuval A Patel, Andrew J Muir
Clinics in Liver Disease|November 18, 2022
Evaluation of an Abnormal Liver Panel After Liver TransplantationJacqueline B Henson, Andrew J Muir
Pageof 19

Showing results (21-30 of 187) with videos related to

Sort By:
Pageof 19
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 12, 2017
Hepatocellular Carcinoma SurveillanceJanice H Jou, Andrew J Muir
The New England Journal of Medicine|June 29, 2012
Overcoming barriers to care for hepatitis CPaul J Clark, Andrew J Muir
Journal of Clinical Gastroenterology|June 25, 2002
A survey of current liver biopsy practice patternsAndrew J Muir, James F Trotter
Hepatology (Baltimore, Md.)|November 30, 2006
Growth factors during HCV therapy may be "cost-effective", but are they "effective"?Andrew J Muir, John G McHutchison
Gastroenterology Clinics of North America|September 7, 2011
Emerging therapies in hepatitis C: dawn of the era of the direct-acting antiviralsAlison B Jazwinski, Andrew J Muir
Therapeutic Advances in Chronic Disease|November 17, 2015
Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomesJulius M Wilder, Andrew J Muir
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 22, 2019
Great Expectations: Can Magnetic Resonance Elastography Accelerate Progress in Primary Sclerosing Cholangitis Research?Mustafa R Bashir, Andrew J Muir
Gastroenterology & Hepatology|April 30, 2011
Direct-acting antiviral medications for chronic hepatitis C virus infectionAlison B Jazwinski, Andrew J Muir
JAMA|July 20, 2016
Evaluation of New-Onset AscitesYuval A Patel, Andrew J Muir
Clinics in Liver Disease|November 18, 2022
Evaluation of an Abnormal Liver Panel After Liver TransplantationJacqueline B Henson, Andrew J Muir
Pageof 19